Literature DB >> 17157627

Ovarian cancer.

Svetlana Mironov1, Oguz Akin, Neeta Pandit-Taskar, Lucy E Hann.   

Abstract

Imaging has become an essential part of the clinical management of patients with ovarian cancer, contributing to tumor detection, characterization, staging, treatment planning, and follow-up. Imaging findings incorporated into the clinical impression assist in creating a treatment plan specific for an individual patient. Advances in cross-sectional imaging and nuclear medicine (PET) have yielded new insights into the evaluation of tumor prognostic factors. A multimodality approach can satisfy the complex imaging needs of a patient with ovarian cancer; however, the success of such an approach always depends on available resources and on the skills of the physicians involved.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17157627     DOI: 10.1016/j.rcl.2006.10.012

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  11 in total

1.  Epithelial membrane protein-2 is a novel therapeutic target in ovarian cancer.

Authors:  Maoyong Fu; Erin L Maresh; Robert A Soslow; Mohammad Alavi; Vei Mah; Qin Zhou; Alexia Iasonos; Lee Goodglick; Lynn K Gordon; Jonathan Braun; Madhuri Wadehra
Journal:  Clin Cancer Res       Date:  2010-08-01       Impact factor: 12.531

2.  18F-FDG PET/CT evaluation of patients with ovarian carcinoma.

Authors:  Andrei H Iagaru; Erik S Mittra; Iain Ross McDougall; Andrew Quon; Sanjiv Sam Gambhir
Journal:  Nucl Med Commun       Date:  2008-12       Impact factor: 1.690

3.  Multidetector CT predictors of incomplete resection in primary cytoreduction of patients with advanced ovarian cancer.

Authors:  Dae Chul Jung; Sokbom Kang; Min Ju Kim; Sang Yoon Park; Hyun Beom Kim
Journal:  Eur Radiol       Date:  2009-08-06       Impact factor: 5.315

4.  How close is the bench to the bedside? Metabolic profiling in cancer research.

Authors:  Que N Van; Timothy D Veenstra
Journal:  Genome Med       Date:  2009-01-20       Impact factor: 11.117

5.  Study on the characteristics of contrast-enhanced ultrasound and its utility in assessing the microvessel density in ovarian tumors or tumor-like lesions.

Authors:  Junyan Wang; Faqin Lv; Xiang Fei; Qiuli Cui; Longxia Wang; Xuewen Gao; Zhixian Yuan; Qian Lin; Yali Lv; Aijun Liu
Journal:  Int J Biol Sci       Date:  2011-05-13       Impact factor: 6.580

6.  Contrast-enhanced ultrasonography in differential diagnosis of benign and malignant ovarian tumors.

Authors:  Jing-Jing Qiao; Jing Yu; Zhe Yu; Na Li; Chen Song; Man Li
Journal:  PLoS One       Date:  2015-03-12       Impact factor: 3.240

7.  The Value of Diffusion-Weighted Imaging in the Differential Diagnosis of Ovarian Lesions: A Meta-Analysis.

Authors:  Hyun-Jung Kim; So-Yeon Lee; Yu Ri Shin; Chang Suk Park; Kijun Kim
Journal:  PLoS One       Date:  2016-02-23       Impact factor: 3.240

8.  Hormone receptors expression in ovarian cancer taking into account menopausal status: a retrospective study in Chinese population.

Authors:  Fang Shen; Xuyin Zhang; Yiqun Zhang; Jingxin Ding; Qi Chen
Journal:  Oncotarget       Date:  2017-08-14

9.  Leptomeningeal carcinomatosis and bilateral internal auditory canal metastases from ovarian carcinoma.

Authors:  Martin Krupa; Kathy Byun
Journal:  Radiol Case Rep       Date:  2017-04-05

10.  Positron emission tomography in ovarian cancer: 18F-deoxy-glucose and 16alpha-18F-fluoro-17beta-estradiol PET.

Authors:  Yoshio Yoshida; Tetsuji Kurokawa; Tetuya Tsujikawa; Hidehiko Okazawa; Fumikazu Kotsuji
Journal:  J Ovarian Res       Date:  2009-06-16       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.